Assyro AI
FDA 483 Database

FDA Form 483s Issued in September 2023

Every published Form FDA 483 issued in September 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

10

Published 483s in September 2023

10

Distinct firms

Form 483s issued in September 2023

Rovi Pharma Industrial Services S.A.FDA
FEI
3016688535
Issued
Sep 22, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Spain
Oishi Koseido Co., Ltd.FDA
FEI
3010166685
Issued
Sep 1, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Zhejiang Peptides Biotech Co, Ltd.FDA
FEI
3015685285
Issued
Sep 7, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Samsung Bioepis Co., Ltd.FDA
FEI
3010031951
Issued
Sep 15, 2023
Establishment
Sponsor
Location
Republic of Korea
Sichuan Deebio Pharmaceutical Co. Ltd.FDA
FEI
3011139911
Issued
Sep 8, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Precision Equine LLCFDA
FEI
3005698544
Issued
Sep 22, 2023
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
California, United States
ModernaTX, Inc.FDA
FEI
3014937058
Issued
Sep 21, 2023
Establishment
Drug Manufacturer
Location
Massachusetts, United States
Pine Pharmaceuticals LLCFDA
FEI
3010943533
Issued
Sep 19, 2023
Establishment
Outsourcing Facility
Location
New York, United States
Samsung Biologics Co. Ltd.FDA
FEI
3010479596
Issued
Sep 1, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
South Korea
Strive Pharmacy Texas LLCFDA
FEI
3015826784
Issued
Sep 8, 2023
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Texas, United States

Other months in 2023

Back to the FDA 483 Database